Abstract
This review provides a detailed account on the biological activities of structurally diverse secondary metabolites from marine sponges having 2-aminoimidazole, glycociamidine and/or 2-thiohydantoin ring functions. This review will complement two previous short reviews which did however not address the potential of these natural products for drug discovery. We will discuss the naturally occurring alkaloids and give an account on their structure activity relationships.
Keywords: 2-Aminoimidazole alkaloids, anticancer, antihistaminic, antimicrobial, Glycociamidine, 2-Thiohydantoin, drug discovery, Nagelamides, bioactive agents
Current Drug Targets
Title: 2-Aminoimidazole, Glycociamidine and 2-Thiohydantoin-Marine Alkaloids as Molecular Inspirations for the Development of Lead Structures
Volume: 12 Issue: 11
Author(s): Ravi Kumar, Shahnawaz Khan and Prem M.S. Chauhan
Affiliation:
Keywords: 2-Aminoimidazole alkaloids, anticancer, antihistaminic, antimicrobial, Glycociamidine, 2-Thiohydantoin, drug discovery, Nagelamides, bioactive agents
Abstract: This review provides a detailed account on the biological activities of structurally diverse secondary metabolites from marine sponges having 2-aminoimidazole, glycociamidine and/or 2-thiohydantoin ring functions. This review will complement two previous short reviews which did however not address the potential of these natural products for drug discovery. We will discuss the naturally occurring alkaloids and give an account on their structure activity relationships.
Export Options
About this article
Cite this article as:
Kumar Ravi, Khan Shahnawaz and M.S. Chauhan Prem, 2-Aminoimidazole, Glycociamidine and 2-Thiohydantoin-Marine Alkaloids as Molecular Inspirations for the Development of Lead Structures, Current Drug Targets 2011; 12 (11) . https://dx.doi.org/10.2174/138945011798109428
DOI https://dx.doi.org/10.2174/138945011798109428 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Exploring Old Drugs for the Treatment of Hematological Malignancies
Current Medicinal Chemistry PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
Current Medicinal Chemistry Role of Flavonoids in Future Anticancer Therapy by Eliminating the Cancer Stem Cells
Current Stem Cell Research & Therapy Podophyllotoxin: Current Perspectives
Current Bioactive Compounds Innate Immunity and Intracellular Trafficking: Insights for Novel Anti- HIV-1 Therapeutics
Current Pharmacogenomics Chromatin Remodeling Agents for Cancer Therapy
Reviews on Recent Clinical Trials Anticancer Drugs Discovery and Development from Marine Organisms
Current Topics in Medicinal Chemistry Advances in Nanocarriers for Anticancer Drugs Delivery
Current Medicinal Chemistry Small Molecule Tyrosine Kinase Inhibitors: The New Dawn for Cancer Therapy
Letters in Drug Design & Discovery Pyridine Based Antitumour Compounds Acting at the Colchicine Site
Current Medicinal Chemistry Polymorphisms of Human N-Acetyltransferases and Cancer Risk
Current Drug Metabolism Driving Neural Stem Cells Towards a Desired Phenotype
Current Stem Cell Research & Therapy Potential Benefits of Glitazones for Cancer and Vascular Disease
Current Drug Therapy Targeted Cancer Therapy: The Next Generation of Cancer Treatment
Current Drug Discovery Technologies A Phosphoproteomics Approach to Identify Candidate Kinase Inhibitor Pathway Targets in Lymphoma-Like Primary Cell Lines
Current Drug Discovery Technologies Interferon Treatment in Patients with Hypereosinophilia
Current Drug Targets MicroRNAs as Regulators in Normal Hematopoietic and Leukemia Stem Cells: Current Concepts and Clinical Implications
Current Molecular Medicine Treatment Strategies for Multiple Myeloma in the Age of Novel Therapies
Current Cancer Therapy Reviews Clinical Immunotherapy of B-Cell Malignancy Using CD19-Targeted CAR T-Cells
Current Gene Therapy Genetics of Bladder Malignant Tumors in Childhood
Current Genomics